Oxford Nanopore Technologies PLC
LSE:ONT

Watchlist Manager
Oxford Nanopore Technologies PLC Logo
Oxford Nanopore Technologies PLC
LSE:ONT
Watchlist
Price: 168.4 GBX -2.6% Market Closed
Market Cap: £1.6B

Operating Margin

-75.1%
Current
Improving
by 8.6%
vs 3-y average of -83.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-75.1%
=
Operating Income
£-153.7m
/
Revenue
£204.7m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-75.1%
=
Operating Income
GBX-153.7m
/
Revenue
£204.7m

Peer Comparison

Country Company Market Cap Operating
Margin
UK
Oxford Nanopore Technologies PLC
LSE:ONT
1.6B GBP
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
238.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
168.1B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.7B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.4B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.3B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.2B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Lower than 95% of companies in United Kingdom
Percentile
5th
Based on 3 579 companies
5th percentile
-75.1%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

Oxford Nanopore Technologies PLC
Glance View

Oxford Nanopore Technologies PLC stands as a pioneering force in the field of genomics, transforming the landscape of DNA and RNA sequencing. Founded as a spin-off from the University of Oxford, the company gained recognition with its distinctive nanopore sequencing technology, which radically differs from traditional sequencing methods. Traditional sequencing often involves a process that can be expensive, time-consuming, and complex. However, Oxford Nanopore's approach uses tiny, porous apertures coupled with electrical signals to read genetic codes directly. This technology allows for the sequencing of long DNA strands in real-time, providing not only speed and efficiency but also the versatility to handle a wide range of samples, from environmental to clinical applications. By making sequencing more accessible and portable through their critically acclaimed MinION device, the company has managed to capture significant interest and investment from researchers across diverse scientific fields. The business model of Oxford Nanopore Technologies is built upon a strategic blend of product sales, including their sequencing devices and associated consumables, alongside providing commercial sequencing services. Their revenue streams are anchored by the MinION, GridION, and PromethION devices, each catering to varied throughput needs and scales of operation. Sales of these devices are complemented by a continuous income from consumable sales, essential for each sequencing run, which helps to embed their technology deeply within the workflows of their users. Additionally, the company's expansion into data analysis services further diversifies their income, utilizing their specialized expertise to assist customers in interpreting and utilizing complex genomic data. This multifaceted approach not only solidifies their position in the genomics market but also ensures multiple pathways for generating sustained revenue growth.

ONT Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-75.1%
=
Operating Income
£-153.7m
/
Revenue
£204.7m
What is Oxford Nanopore Technologies PLC's current Operating Margin?

The current Operating Margin for Oxford Nanopore Technologies PLC is -75.1%, which is above its 3-year median of -83.7%.

How has Operating Margin changed over time?

Over the last 3 years, Oxford Nanopore Technologies PLC’s Operating Margin has decreased from -73.7% to -75.1%. During this period, it reached a low of -101.8% on Jun 30, 2024 and a high of -49.6% on Dec 31, 2022.

Back to Top